MedTrace Logo

DNA Variations in the Gene in Young Patients With Wilms' Tumor

NCT00088803 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 471

Last updated 2016-05-19

No results posted yet for this study

Summary

RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that may occur in DNA and identify biomarkers related to cancer.

PURPOSE: This laboratory study is looking at DNA variations in the RASSF1A gene in young patients with Wilms' tumor.

Conditions

Interventions

GENETIC

molecular genetic technique

GENETIC

polymerase chain reaction

GENETIC

polymorphism analysis

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Children's Oncology Group

    lead NETWORK

Principal Investigators

  • Gail E. Tomlinson, MD, PhD · Simmons Cancer Center

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-08-31
Primary Completion
2016-05-31

Countries

  • United States
  • Australia
  • Canada
  • Netherlands
  • New Zealand
  • Puerto Rico
  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00088803 on ClinicalTrials.gov